Navigation Links
Silicone Rubber Flap Restore Speech

Marein van der Torn and his colleagues at the Vrije University in Amsterdam in collaboration with the University of Groningen developed a new mechanism for vocal sound. //

Usually in case of throat cancer the larynx or the voice box as it is called has to be surgically removed.

The patients after this surgery find it very difficult to talk with the rubber silicone artificial valve. This valve is implanted in-between the windpipe and oesophagus.

But after this surgery though the patient can converse their voice is rough and is very low pitched and not audible.

Female patients find it very difficult to adjust after the surgery as the voice cannot be clearly understood.

The new discovery is of great help to the female patients. The new valve synthesizes its own sound.

The valve consists of a small silicone flap which is implanted in place of the vocal cord that has been removed. Two flaps each of them unique to male and female was developed.

The mechanism with which it works is the vibrations felt by the flap, air resistance and the vocal sound was produced. All of which were tested in-vitro on a group of patients at the medical centre.

The results were compared with those patients devoid the silicone rubber flap.

The result of this study was that female patients benefited from this new discovery. Their voice from being very week and inaudible became strong and had a distinct female pitch.

But as of now it will not be available in the markets because the flap is easily impaired by the mucous that is coughed out by the patients.

Hence further research has to be conducted on improving its tensile strength at the same time maintaining its elasticity and fragility.


'"/>




Page: 1

Related medicine news :

1. Silicone Implants Make No Significant Difference To Breast Cancer Survivors
2. Potentially Dangerous levels of Platinum Found in Women with Silicone Gel Breast Implants
3. Silicone Leaks Seen Among Women with Breast Implants
4. Canadian Regulators allow Silicone Breast Implants in Market
5. Anti-Cancer Drug Restores Normal Cell Growth
6. Vitamin E Could Restore Sudden Hearing Loss
7. Peaceful Slumber said to Restore Memories
8. Running Water Restored In Chinese City
9. Restore Ban on Weight Loss Aid, Ephedra – FD
10. Gene Therapy May Help Restore Sight In Congenital blindness
11. Blood Flow to Kidneys Better Restored by Less Invasive Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Silicone Rubber Flap Restore Speech

(Date:9/5/2008)...odels are enhanced by taking into account risk fac... according to research teams led by epidemiologist... Center in two complementary papers appearing in t.... , In the first study to focus on African-Ameri...creased exposure to certain risks. Based upon thes...
(Date:9/4/2008)...e Medicare Advantage (MA) plans will be paid an av...red to what the same enrollee would have cost in t...ccording to a new report from The Commonwealth Fun...dated by the Medicare Improvements for Patients an... effect beginning in 2010 had been fully in place...
(Date:9/4/2008)...pancreatic tumors , , THURSDAY, Sept. 4 ...coveries involving genetic mutations of two deadly...reatic cancer -- may lead to new treatments and ev...present the most complete genetic analysis to date...map of these deadly cancers," Kenneth Kinzler, a p...
(Date:9/4/2008)...RNewswire/ -- Martin Schiff, M.D.,is an illustriou...weight,control and weight loss. His career is deta...he West," "Who,s Who in America," "Who,s Who in,th...and other honor rolls., Dr. Schiff recently retir...ate, misleading theories and notions concerning we...
Breaking Medicine News(10 mins):Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:Genetic Mutations Linked to Deadly Cancers 2Health News:Genetic Mutations Linked to Deadly Cancers 3Health News:Genetic Mutations Linked to Deadly Cancers 4Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2
...alyzing the neuronal receptor activity in the post...ia, researchers at the University of Pennsylvania ...ists at the City University of New York, have foun...h level of erbB4 receptor activity and reduced NMD...
...a of subjecting drug addicts to shock therapy as a... debates and controversies. Now, the Scottish Exec...rapy //. Shock therapy technically labeled as Neu...with the use of self-adhesive electrodes inserted ...
...bane childcare center, a tuberculosis case alerts ...diagnosed in a childcare worker, who works at the ...Mount Ommaney in west Brisbane. Dr Michael Whitby... Medical Association (AMA) said that children’s (m...
...ast Victoria Sale Hospital's two pediatricians, Jo...ions with three months notice with three months no...xpected for at least six months. This has led to .... Sale obstetrician Dr Refaat Guirguis has said th...
Other Medicine News:Health News:Schizophrenia Complicates With Altered Receptor Activity 2Health News:Schizophrenia Complicates With Altered Receptor Activity 3
(Date:9/3/2008)... that Multaq(R) (dronedarone) decreased the risk o...n or atrial flutter already adequatel... N.J., Sept. 3 /- The resul...ENA study were presented today at,the clinical tri...ology,congress 2008, in Munich, Germany. Previous ...
(Date:9/3/2008)...erations, Updates Zingo Launch Progress and Adlea ... Conference Call Today at 11:30 am ET,...-FirstCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) anno...ations to focus on commercial and late-stage produ...pecialty pharmaceutical pain management,company. T...
(Date:9/3/2008)...uated in Repeat-Dosing Study in Subjects with ALS,... -- Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) ann... trial (SB-509-801) to evaluate its drug, SB-509, ...motor-neuron disease for which there,are limited t...-509, is an injectable formulation of a plasmid,en...
(Date:9/2/2008).../- Forest Laboratories, Inc...day announced results from,two global Phase III st...nhaled anticholinergic for the treatment of patien...D). In both the ACCLAIM/COPD I&II,(AClidinium CLin...te to,Severe COPD Patients) studies, once-daily ac...
Breaking Medicine Technology:Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6Gerber Scientific to Present at 10th Annual Needham Growth Stock Conference 9000 1Gerber Scientific to Present at 10th Annual Needham Growth Stock Conference 9000 2Transcript of Elizabeth Mazzocchi Press Conference 8996 1Transcript of Elizabeth Mazzocchi Press Conference 8996 2Transcript of Elizabeth Mazzocchi Press Conference 8996 3Transcript of Elizabeth Mazzocchi Press Conference 8996 4Transcript of Elizabeth Mazzocchi Press Conference 8996 5Exelixis Announces January 10 Webcast of Presentation at the 26th Annual JPMorgan Healthcare Conference 2415 1Oncolytics Biotech Inc Announces Filing of Phase 1 2 Clinical Trial with REOLYSIN 28R 29 2411 1Oncolytics Biotech Inc Announces Filing of Phase 1 2 Clinical Trial with REOLYSIN 28R 29 2411 2
...Donnelly, MT (ASCP) Contributing Editor , ,Qu...y to meeting the needs of doctors and patients by ...hods. Vendors of these systems can be a valuable r...tocols to help lab managers ensure that analytical...oping suitable QC materials for today,s laboratori...
...l S. Singer, M.D., Ph.D. Contributing Editor Harva...l for heart failure in African American patients h...espond differently to the same medication. This c...edications, and in many cases is due to individual...ics focuses on these issues, valuable new laborato...
Other Medicine Technology:New Quality Control Systems for Every Laboratory Application 2New Quality Control Systems for Every Laboratory Application 3Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 2Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 3
... Integrity family of pacemakers features several o... today's worldwide pacing market. Offering an unpa...gnostic information, the system builds on the popu...,It incorporates the exclusive ventricular AutoC...
IntelliVue Information Center combines the real-time monitoring surveillance of a central station with sophisticated clinical analysis tools. Moreover, the Information Center is equipped with Philips
...troSpec™, is an imaging agent that provides ...ging for patients five years of age or older with ...llows physicians to see clearly the "function" of ...ing in a reliable diagnosis. NeutroSpec attaches t...
...iTime® is an enterprise-wide staff scheduling ... scheduling process through the synchronization an...automatically generates and maintains staff schedu...nd overtime; manages shift and work location sched...
Medicine Products: